Shanghai Orsin Medical Technology Co., Ltd. miaomiao8615@orsins.com 86-021-57450666
Shanghai Orsin Medical Technology Co., Ltd. ملف الشركة
المنتجات
المنزل > المنتجات > أنبوب اختبار الدم الفراغ > Red Clot Activator Blood Collection Tube for Emergency Testing

Red Clot Activator Blood Collection Tube for Emergency Testing

تفاصيل المنتج

مكان المنشأ: الصين

اسم العلامة التجارية: Orsin

إصدار الشهادات: ISO 13485

رقم الموديل: تنشط جلطة الجل

شروط الدفع والشحن

الحد الأدنى لكمية: 100/pcs

الأسعار: قابل للتفاوض

وقت التسليم: 1-4 أسابيع

شروط الدفع: L/C ، D/A ، D/P ، T/T ، Western Union

القدرة على العرض: 20 مليون/أجهزة الكمبيوتر/العث

احصل على أفضل سعر
نتحدث الآن
تفاصيل المنتج
إبراز:

red clot activator blood tube,emergency blood collection tube,vacuum blood test tube with clot activator

,

emergency blood collection tube

,

vacuum blood test tube with clot activator

سلوك:
تحمل درجة حرارة قوية
ترتيب عينة:
متاح
تسمية الأنبوب:
البطاقة البيضاء
أوامر دفعة مختلطة:
مدعوم
درجة الفراغ:
الضغط السلبي
نشاط الصفائح الدموية:
تم دعم الاستقرار
ملكيات:
دائم وموثوق
المواد الإغلاق:
سدادة المطاط الاصطناعية
أنبوب متخصص:
أنبوب المنشط الجلطة
سعة:
يمكن تخصيصها
حجم الأنبوب:
حجم الأنابيب المخصصة
ميزة:
حماية سلامة العينة
سلوك:
تحمل درجة حرارة قوية
ترتيب عينة:
متاح
تسمية الأنبوب:
البطاقة البيضاء
أوامر دفعة مختلطة:
مدعوم
درجة الفراغ:
الضغط السلبي
نشاط الصفائح الدموية:
تم دعم الاستقرار
ملكيات:
دائم وموثوق
المواد الإغلاق:
سدادة المطاط الاصطناعية
أنبوب متخصص:
أنبوب المنشط الجلطة
سعة:
يمكن تخصيصها
حجم الأنبوب:
حجم الأنابيب المخصصة
ميزة:
حماية سلامة العينة
وصف المنتج

Red Clot Activator Blood Collection Tube Technical Specification and Application Guide

1. Application Scenarios

The Red Clot Activator Tube (commonly known as the "Red Top Tube") is a core consumable for clinical serum testing. Its wall is coated with clot activators to accelerate blood coagulation. Primary applications include:

  • Emergency biochemical testing: Cardiac enzyme panels, liver/kidney function, electrolytes (K⁺/Na⁺/Cl⁻), and other time-sensitive assays

  • Immunological and serological analysis: Thyroid function, tumor markers, infectious disease antibody screening (e.g., HIV)

  • Metabolic and therapeutic drug monitoring: Blood glucose (requires complementary gray-top glycolytic inhibitor tubes), therapeutic drug monitoring (TDM)

Its core value lies in reducing clotting time to 15–20 minutes (vs. ≥60 minutes for natural clotting), significantly improving testing efficiency.


2. Product Highlights and Technical Advantages

Key innovations and advantages of the red clot activator tube:

Feature Performance Benefit
Vascular-mimetic Silicone Coating Silicone-treated walls prevent cell adhesion, eliminating hemolysis or pseudohyperkalemia during centrifugation
Uniform Spray Clot Activation Nano-scale spray coating ensures full blood-activator contact, accelerating clotting by 3–4× (deep coagulation in 15 min)
High-Purity Serum Separation Transparent serum post-centrifugation (3,500–4,000 rpm); fibrin residue rate <0.1%, eliminating instrument probe clogging
Broad-Temperature Adaptability Maintains efficacy at 0–37°C; below 16°C, increase inversions to sustain performance

3. Usage Precautions

Operational compliance is critical for accuracy. Strictly adhere to:

  1. Mixing Protocol: Immediately invert tube 5–8 times at 180° after collection to ensure full blood-activator contact and prevent fibrin formation.

  2. Temperature Control:

    • Ambient temperature <20°C: Increase inversions to 8–10 times or use a 36°C water bath.

    • Centrifuge at 25°C to avoid gelatinous clots.

  3. Clotting Time: Allow 15–20 minutes for complete coagulation before centrifugation (premature spinning causes fibrin threads).

  4. Storage & Shelf Life:

    • Refrigerate opened tubes at 4°C; use within 1 week.

    • Discard if activators show granulation, odor, or discoloration.


4. Troubleshooting

Solutions for common issues:

  • Fibrin Threads/Gelatinous Clot:
    Cause: Incomplete clotting or premature centrifugation.
    Resolution: Extend room-temperature standing time to 30 min; re-centrifuge. For recurring cases, check activator coating uniformity.

  • Mild Hemolysis:
    Cause: Insufficient mixing in cold environments or excessive mechanical agitation.
    Resolution: Use inversion mixing (not shaking); pre-warm tubes to 25°C in cold conditions.

  • Insufficient Serum Yield:
    Cause: Underfilled tube (e.g., <2mL in a 3mL tube) or vacuum loss.
    Resolution: Replace tube; verify needle seal integrity.

  • Wall Adhesion/Cell Residue:
    Cause: Silicone coating failure or inadequate centrifugation (<3,500 rpm).
    Resolution: Centrifuge at 4,000 rpm × 10 min; use tubes from qualified batches.

  •  

  • 5. Basic Specifications

Parameter Specification
Volume Standard: 1mL-10mL (larger volumes for multi-test panels)
Material Glass (heat-resistant) or PET plastic (shatterproof); Ø13–16mm × H75–100mm
Clot Activator Spray-dried silica composite (enzyme-free to avoid immunoassay interference)
Centrifugation 3,500–4,000 rpm for 5–10 min; gel-barrier tubes tolerate up to 5,000 rpm
Packaging 100 tubes/box or 1,800 tubes/carton

 

Summary

The red clot activator tube is the preferred choice for emergency and biochemical testing due to its rapid clotting, high-purity serum, and broad temperature adaptability. Optimal performance requires strict adherence to mixing protocols, temperature control, and centrifugation timing to avoid fibrin residue or hemolysis. For high-precision tests (e.g., tumor markers), gel-barrier activator tubes (gold cap) are recommended for superior serum quality.

 

This translation maintains technical accuracy while adapting terminology to international medical standards (e.g., CLSI guidelines). Key metrics (rpm, temperature ranges) and proprietary terms (brand names) are preserved per industry conventions.

منتجاتنا
منتجات مماثلة